microbicidal activity of c31g against n. gonorrhoeae under conditions that mimic the in vivo situation.

NLM AIDSLINE Microbicidal activity of C31G against N. gonorrhoeae under conditions that mimic the in vivo situation. Malamud D; Douglas A; Rest R; Biosyn, Phila., PA. Fax: 215-387-5332.
January 30, 1997

Int Conf AIDS. 1996 Jul 7-12;11(2):16 (abstract no. We.A.510). Unique Objective: To extend our studies on the range of activities of a C31G-based microbicide to include isolates of Neisseria gonorrhoeae that are sialylated on the terminal galactose moiety of the gonococcal lipooligosaccharide and/or grown anaerobically, and thus mimic the in vivo situation. Methods: C31G is a broad-spectrum agent effective against gram positive and gram negative bacteria, fungi, and enveloped viruses. It is composed of an equimolar mixture of an alkyl amine N-oxide and an alkyl N-dimethylglycine (betaine), buffered with citric acid. The chemical and physical properties of C31G can be altered by changing the length of the alkyl chains. In the present study, alkyl chain lengths of C12 vs C14/C16 were evaluated for efficacy against N. gonorrhoeae strain F62. Bacteria were grown under either aerobic or anaerobic conditions, and in the presence or absence of CMP-NANA to generate sialylated and non-sialylated surface lipooligosaccahrides. The efficacy of C31G was evaluated by determining the Minimum Inhibitory Concentration (MIC). Results: The C14/C16 form of C31G consistently showed increased efficacy as compared to the shorter alkyl chain C12 form (MIC's of 0.00032% vs .00125%). As expected, sialylated forms of N. gonorrhoeae demonstrated resistance to human serum bacteriocidal activity as compared with non-sialylated bacteria. On the other hand, the effects of the microbicide C31G were not diminished either by growth in anaerobic conditions, or by sialylation of the gonococci. Conclusions: C31G is currently under evaluation for use as a vaginal microbicide. Previous studies have shown efficacy against a variety of STD pathogens including HIV, HSV, Treponema, Chlamydia, H. ducreyi and C. albicans. In the present study, the compound has demonstrated potent in vitro activity against N. gonorrhoeae under conditions expected in vivo anaerobic and sialylation of surface lipooligosaccharides). 33505 and HD 3-3193. Betaine/CHEMISTRY Neisseria gonorrhoeae/DRUG EFFECTS *Sexually Transmitted Diseases/DRUG THERAPY

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases Toronto Public Health urges vaccination against bacterial meningitis for MSM travelling to New York Rights Group Documents 'Serious Abuses' Against Sex Workers in China Rights group urges China to repeal penalties against sex workers Scientists Develop Experimental Vaccine Against Heroin ITALY: HIV Meds Protect Against Doubled Cancer Risk in Positive Men Jewelry Designer And Tattoo Artist Join Forces Against AIDS KYRGYZSTAN: Germany to Grant Kyrgyzstan €11.5 M for Fight Against Tuberculosis Climbing against gender-based violence: A quest for dignity, equality and justice AUSTRALIA: Study Shows HPV Vaccine Successful Against Genital Warts
Information in this article was accurate in January 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.